NeoGenomics, Inc. Other Asset Impairment Charges
NeoGenomics, Inc. (NEO) reported Other Asset Impairment Charges of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2025-10-28
- NeoGenomics, Inc. other asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- NeoGenomics, Inc. other asset impairment charges for the quarter ending 2024-09-30 was $0.00.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-29 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $333.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $333.00K 10-Q · filed 2025-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |